Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Renewal of Skin Epidermal Stem Cells01:12

Renewal of Skin Epidermal Stem Cells

The skin is divided into epidermis, dermis, and hypodermis, the skin's outermost, middle, and inner layers. The human epidermal layer regularly undergoes renewal, where old, dead cells are replaced by new cells. Epidermal stem cells or EpiSCs divide and differentiate to restore the lost cells. For the renewal process, some EpiSCs continuously self-renew. In contrast, few others differentiate into transit-amplifying cells, which later form prickle or spinous cells, followed by granular cells,...
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Correction: Decoding distinctive features of plasma extracellular vesicles in amyotrophic lateral sclerosis.

Molecular neurodegeneration·2026
Same author

IFRA: A Machine Learning-Based Instrumented Fall Risk Assessment Scale Derived from an Instrumented Timed Up and Go Test in Stroke Patients.

Healthcare (Basel, Switzerland)·2026
Same author

Understanding Long-Term Survival in ALS: A Cohort Study on Subject Characteristics and Prognostic Factors.

Journal of clinical medicine·2025
Same author

A Short Version of Carers' Quality of Life Questionnaire for Parkinsonism: Data from Progressive Supranuclear Palsy Network.

Movement disorders clinical practice·2025
Same author

De novo seven extra repeat expanded mutation in the PRNP gene in an Italian patient with early onset dementia.

BMJ case reports·2025
Same author

AGREE: an upper limb motorized exoskeleton for restoring arm functions: a single-blinded randomized controlled trial.

Journal of neuroengineering and rehabilitation·2025

相关实验视频

Updated: Jul 13, 2026

Human Dupuytren's Ex Vivo Culture for the Study of Myofibroblasts and Extracellular Matrix Interactions
08:59

Human Dupuytren's Ex Vivo Culture for the Study of Myofibroblasts and Extracellular Matrix Interactions

Published on: April 18, 2015

干细胞治疗肌缩侧面硬化症的干细胞治疗.

Vincenzo Silani1, Lidia Cova, Massimo Corbo

  • 1Department of Neurology and Laboratory of Neuroscience, Dino Ferrari Centre, University of Milan Medical School-IRCCS Istituto Auxologico Italiano, Milano, Italy. Silanivincenzo@silani.com

Lancet (London, England)
|July 13, 2004
PubMed
概括

干细胞疗法显示,通过潜在地替换受损的运动神经元,对肌缩性侧面硬化症 (ALS) 有希望. 进一步的临床前研究对于优化这种细胞替代策略来治疗ALS至关重要.

科学领域:

  • 神经科学是一个神经科学.
  • 再生医学是一种再生医学.
  • 干细胞生物学 干细胞生物学

背景情况:

  • 肌缩侧面硬化症 (ALS) 缺乏有效的药物治疗,使干细胞治疗成为一个有希望的途径.
  • 在动物模型中进行的临床前研究表明,干细胞移植有可能恢复功能或延迟神经退行.
  • 成人干细胞的转基因分化能力为ALS的基于细胞的治疗提供了新的可能性.

研究的目的:

  • 探索干细胞移植的潜力,作为一种治疗性策略,用于肌缩侧面硬化症 (ALS).
  • 审查ALS的干细胞治疗的临床前证据和早期临床安全数据.

主要方法:

  • 在神经退行性疾病模型中对干细胞移植进行临床前研究的审查.
  • 对克莱门特等人研究结果的分析. (2003) 关于非神经元细胞在运动神经元退化中的作用.
  • 检查马齐尼等人的研究. (2003年) 对ALS患者自身骨髓衍生干细胞的研究.

主要成果:

  • 非神经元细胞,如野生类型的质细胞,可以延迟SOD1G93A小鼠的运动神经元退化.
  • 自主骨髓衍生干细胞注射到ALS患者的脊髓中证明了临床安全性.
  • 动物模型的早期成功表明,干细胞治疗可以恢复功能或延迟退化.

更多相关视频

Improving 2D and 3D Skin In Vitro Models Using Macromolecular Crowding
09:14

Improving 2D and 3D Skin In Vitro Models Using Macromolecular Crowding

Published on: August 22, 2016

A Simplified and Efficient Method to Isolate Primary Human Keratinocytes from Adult Skin Tissue
06:17

A Simplified and Efficient Method to Isolate Primary Human Keratinocytes from Adult Skin Tissue

Published on: August 25, 2018

相关实验视频

Last Updated: Jul 13, 2026

Human Dupuytren's Ex Vivo Culture for the Study of Myofibroblasts and Extracellular Matrix Interactions
08:59

Human Dupuytren's Ex Vivo Culture for the Study of Myofibroblasts and Extracellular Matrix Interactions

Published on: April 18, 2015

Improving 2D and 3D Skin In Vitro Models Using Macromolecular Crowding
09:14

Improving 2D and 3D Skin In Vitro Models Using Macromolecular Crowding

Published on: August 22, 2016

A Simplified and Efficient Method to Isolate Primary Human Keratinocytes from Adult Skin Tissue
06:17

A Simplified and Efficient Method to Isolate Primary Human Keratinocytes from Adult Skin Tissue

Published on: August 25, 2018

结论:

  • 干细胞治疗是ALS治疗的可行候选者,得到了临床前数据和转化潜力的支持.
  • 由于恢复神经元连接的复杂性,ALS的成功细胞替代疗法需要强有力的临床前证据.
  • 未来的ALS干细胞疗法可能需要组合方法,包括药物,抗氧化剂或热带分子.